KG-207

N/A

Report date: 2024/11/18 13:25:57

Base Information

Drug NameKG-207
Drug Alias NameKG-207
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKalgene Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesKalgene Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A